SCHEMBL9681422

SCHEMBL9681422

Nc1cc(F)ccc1NCc1ccc(Br)cc1F

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.40
AKR1B1 P15121 4/20 0.40
AKR1A1 P14550 2/20 0.40
KDM1A O60341 1/20 0.39
NTRK1 P04629 3/20 0.39
ADRA2B P18089 1/20 0.38
AKR1B10 O60218 1/20 0.38
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.36
IDO1 P14902 1/20 0.36
AGXT P21549 1/20 0.36
HSP90B1 P14625 1/20 0.36
TRAP1 Q12931 1/20 0.36
AURKA O14965 1/20 0.36
RPS6KB1 P23443 1/20 0.36
AURKB Q96GD4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683479 0.86 AKR1B1 (0.43) AKR1B1AKR1A1KDM1AADRA2BALDH1A1
SCHEMBL9681871 0.80 MAPT (0.43) HDAC1ALDH1A1MAPT
SCHEMBL9682000 0.77 MAPT (0.51) ALDH1A1MAPT
SCHEMBL25828139 0.76 PTGER4 (0.56) ALDH1A1MAPTKDM4E
SCHEMBL10487973 0.74 AKR1B1 (0.57) AKR1B1AKR1A1
SCHEMBL9683520 0.74 TRPM5 (0.43) HDAC1AKR1B1ADRA2BALDH1A1
SCHEMBL5180846 0.73 MEN1 (0.53) NTRK1ADRA2BALDH1A1MAPTKDM4E
SCHEMBL11158402 0.72 KDM1A (0.48) AKR1B1AKR1A1KDM1AHSP90B1TRAP1
SCHEMBL5537895 0.72 KDM1A (0.46) AKR1B1KDM1AALDH1A1
SCHEMBL12658350 0.71 SHMT2 (0.48) HDAC1ALDH1A1MAPTAURKARPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5128359-A Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation LABORATOIRES UPSA (FR) 1992-07-07 US disclosed
US-5124336-A Cardiovascular disorders LABORATOIRES UPSA (FR) 1992-06-23 US disclosed